Article Details

GSK, Alector to develop Parkinson's, Alzheimer's drugs in $2.2 billion deal

Retrieved on: 2021-07-02 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

GSK, Alector to develop Parkinson's, Alzheimer's drugs in $2.2 billion deal. View article details on hiswai:

Excerpt

The candidates belong to a class of medicines called monoclonal antibodies used in immunotherapy, where the body's own defences are used to fight ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo